Absorbable Nasal Implant Devices Market
According to Intent Market Research, the Absorbable Nasal Implant Devices Market is expected to grow from USD 417.4 million in 2023 at a CAGR of 11.8% to touch USD 912.4 million by 2030. The Absorbable Nasal Implant Devices Market is dominated by key players such as, Acelity L.P. Inc., Acclarent, Inc., EpiBone, Entellus Medical, Inc. (part of Stryker), and Genzyme Corporation (part of Sanofi).